Sculptor Capital LP

Q3 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2023
Date filed
11/14/2023
Form type
13F-HR
Num holdings
586
Total value ($000)
$4,971,971
Net value change ($000)
-67,024 (-1.3%)
New positions
40
Sold out positions
55
Turnover %
56.4%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
FWONA 394,145 NEW
AIY 365,680 276.8%
FWONA 101,899 NEW
FCNCA 44,170 177.9%
CDNS 44,048 NEW
FWONA 41,682 NEW
CHTR 41,383 15.6%
AMZN 36,259 37.1%
FWONA 35,856 NEW
SNPS 35,065 NEW
Top Reduces (Value $000, Stocks/ETFs)
FWONA -476,263 -100.0%
FWONA -117,962 -100.0%
PCG -93,294 -100.0%
WK -63,236 -94.7%
Horizon Therapeutics Public Ltd Co -58,666 -54.2%
INTC -53,036 -100.0%
FWONA -49,850 -100.0%
WDAY -45,155 -100.0%
FWONA -41,348 -100.0%
MSFT -41,117 -18.2%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 865,043 (17.4% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Sculptor Capital II LP 028-13627